Stray Field NMR Scanner for Early Osteoporosis Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting osteoporosis and osteopenia are ineffective in identifying preclinical stages before clinical indications appear, and they often require invasive or late-stage diagnostic techniques like X-ray absorptiometry or MRI.
Innovation Solution
A method using a stray field non-homogeneous NMR scanner to detect changes in bone marrow cellular composition by analyzing T1 relaxation time, T2 relaxation time, and apparent diffusion coefficient, allowing for early detection of adipose tissue content indicative of osteoporosis or osteopenia without imaging pulses, and providing feedback on treatment efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If X-ray absorptiometry or MRI is used to detect bone conditions, then diagnostic accuracy is improved, but the detection can only be performed at later stages when clinical indications are already apparent
Solution Approach 1:
The patent replaces traditional X-ray and MRI mechanical/imaging systems with NMR spectroscopy that uses magnetic fields and radiofrequency pulses to detect bone marrow composition changes. This substitution enables detection of preclinical osteoporosis through biochemical markers (adipose tissue content) before structural changes become visible on X-ray, resolving the contradiction between detection accuracy and detection timing.
2Loss of information
If traditional imaging methods like MRI are used, then detailed bone structure information is obtained, but the equipment complexity and cost increase significantly
Solution Approach 1:
The patent extracts only the essential information needed for early osteoporosis detection (bone marrow composition, specifically adipose tissue content) using NMR spectroscopy, rather than obtaining complete structural images with MRI. This extraction approach maintains sufficient diagnostic information while dramatically simplifying equipment requirements and reducing cost.
Solution Approach 2:
The patent employs a portable NMR scanner that is significantly cheaper and simpler than traditional MRI equipment. The system uses a handheld or portable design with permanent magnets and simple RF coils, making it accessible for routine screening without the complex infrastructure requirements of hospital-based MRI systems.
3Measurement precision
If invasive procedures are used for early detection, then diagnostic precision is improved, but patient comfort and ease of operation deteriorate
Solution Approach 1:
The NMR spectroscopy method is completely non-invasive, requiring only placement of the portable scanner against the patient's skin over the bone of interest. The procedure automatically collects data without needles, injections, or complex preparation, maintaining high diagnostic precision for detecting bone marrow composition changes while ensuring maximum patient comfort and ease of operation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables non-invasive, early detection of preclinical osteoporosis or osteopenia, allowing for timely intervention before bone mineral density decreases, using a portable scanner that can detect changes in adipose tissue content before cortical bone changes are visible on X-ray.
Implementation Method 1
NMR measurements obtained using a stray field non-homogeneous NMR scanner
Implementation Method 2
analyzing T1 relaxation time
Implementation Method 3
analyzing T2 relaxation time
Implementation Method 4
apparent diffusion coefficient
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A method for early detection of bone deficiency in a patient, comprising: collecting NMR signals of a bone marrow volume in a bone of the patient having normal bone density levels which are not indicative of bone deficiency as indicated by X-ray; and analyzing said collected NMR signals to detect at least a presence or absence of a preclinical stage of bone deficiency in said bone.